Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
QuintilesIMS
Deloitte
Covington
Harvard Business School
Farmers Insurance
Federal Trade Commission
Daiichi Sankyo
US Army

Generated: May 26, 2018

DrugPatentWatch Database Preview

Supergen Company Profile

« Back to Dashboard

What is the competitive landscape for SUPERGEN, and what generic and branded alternatives to SUPERGEN drugs are available?

SUPERGEN has one approved drug.



Summary for Supergen
US Patents:0
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Supergen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Supergen MITOZYTREX mitomycin INJECTABLE;INJECTION 050763-001 Nov 14, 2002 DISCN Yes No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Cantor Fitzgerald
Farmers Insurance
Healthtrust
Accenture
Argus Health
Covington
Federal Trade Commission
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.